Home Issues Collections CME Ahead-of-Print Online-Only Blog Podcasts For Authors Journal Info AAPA
Skip Navigation LinksHome > July 2013 - Volume 26 - Issue 7 > GnRH receptor antagonists for prostate cancer
Journal of the American Academy of Physician Assistants:
doi: 10.1097/01.JAA.0000431511.13196.28
What's New in Oncology

GnRH receptor antagonists for prostate cancer

Patrick, Emily; Whitson, Melissa; Smith, Amy; Parnell, Jamin; Thomas, Suzanne E. PhD; Blankenship, Clint C. PharmD, PA-C

Collapse Box

Abstract

ABSTRACT: GnRH receptor antagonists can reduce testosterone levels without the adverse reactions caused by other drugs used to treat prostate cancer. These drugs also offer hope for prolonged control of metastasis.

© 2013 American Academy of Physician Assistants.

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Readers Of this Article Also Read